Impact of residual coronary artery disease on patients undergoing TAVI. A meta-analysis of adjusted observational studies

Degenerative aortic valve disease requiring transcatheter aortic valve implantation (TAVI) shares similar risk factors with atherosclerotic coronary artery disease (CAD). For TAVI patients, management of CAD remains unsettled, due to both challenging clinical and interventional features. We conducted a systematic review on the impact of residual CAD on TAVI outcomes, and found that residual or baseline CAD of mild to moderate severity (ie SYNTAX score equal or less than 10) was not significantly associated with adverse outcomes after TAVI